Yingwei Wang
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 15
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 9
- Oncology top 5%
- Peptidase Inhibition and Analysis 11
- Immunology top 10%
-
- Radiomics and Machine Learning in Medical Imaging 9
- MRI in cancer diagnosis 8
- Radiopharmaceutical Chemistry and Applications 7
-
- Pain Mechanisms and Treatments 8
-
- Renal cell carcinoma treatment 6
- Cited by
- NephrologyCancer ResearchOncology
- Journals
- Frontiers in Oncology (5 papers)Scientific Reports (4 papers)Abdominal Radiology (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yingwei Wang
146 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 145
- Nephrology 144
- Cancer Research 285
- Oncology 456
- Immunology 340
- Radiology, Nuclear Medicine and Imaging 271
Countries citing papers authored by Yingwei Wang
This map shows the geographic impact of Yingwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingwei Wang more than expected).
Fields of papers citing papers by Yingwei Wang
This network shows the impact of papers produced by Yingwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingwei Wang. The network helps show where Yingwei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yingwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 19 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 2 | |
| 16 | 2020 | 65 | |
| 17 | 2018 | 23 | |
| 18 | 2017 | 1 | |
| 19 | 2012 | 6 | |
| 20 | Hyalinizing trabecular tumor and papillary carcinoma of the thyroid. | 2010 | 5 |
About Yingwei Wang
Yingwei Wang is a scholar working on Nephrology, Radiology, Nuclear Medicine and Imaging, Neuropsychology and Physiological Psychology, Critical Care and Intensive Care Medicine and Oncology, having authored 156 papers that have together received 2.3k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (15 papers), Peptidase Inhibition and Analysis (11 papers), Radiomics and Machine Learning in Medical Imaging (9 papers), Protease and Inhibitor Mechanisms (9 papers), MRI in cancer diagnosis (8 papers), Pain Mechanisms and Treatments (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Nephrology (144 citations), Cancer Research (285 citations), Oncology (456 citations), Immunology (340 citations) and Radiology, Nuclear Medicine and Imaging (271 citations). Yingwei Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Dan Zhao, Wen Qiu, Xia Zhang, Dawen Niu, Yue Chen, Kai Shan, Haiyi Wang, Huiyi Ye, Fengxia He and Yan Li. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Abdominal Radiology, The FASEB Journal and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.